Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats
- PMID: 15053
- DOI: 10.1111/j.2042-7158.1977.tb11255.x
Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats
Abstract
Imipramine and clomipramine were administered to rats by the oral and intramuscular routes as single and multiple doses. The concentrations of both drugs and their active demethylated metabolites desipramine and desmethylclomipramine were measured in blood plasma, blood cells and brain. The concentrations of the metabolites were higher and the concentrations of the parent substances lower after oral than after parenteral administration, both in blood and in brain. In brain imipramine, despiramine and clomipramine during continuous treatment exceeded their plasma concentrations by six to ten times. The corresponding figure for desmethylclomipramine was 1-7. The extent of accumulation of the investigated substances in the brain was independent of the route of administration.
Similar articles
-
The demethylation of imipramine and clomipramine as apparent from their plasma kinetics.Psychopharmacology (Berl). 1977 Oct 20;54(2):125-31. doi: 10.1007/BF00426767. Psychopharmacology (Berl). 1977. PMID: 412206
-
Determination of clomipramine or imipramine and their mono-demethylated metabolites in human blood or plasma by high-performance liquid chromatography.J Chromatogr. 1981 Jan 16;204:303-11. doi: 10.1016/s0021-9673(00)81672-6. J Chromatogr. 1981. PMID: 7217258
-
On the kinetics of imipramine and related antidepressants.Acta Psychiatr Scand Suppl. 1980;280:147-56. Acta Psychiatr Scand Suppl. 1980. PMID: 6931475 No abstract available.
-
Plasma levels of imipramine and desipramine in man after different routes of administration.Naunyn Schmiedebergs Arch Pharmacol. 1975;290(2-3):145-60. doi: 10.1007/BF00510547. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 1102994 Clinical Trial.
-
The clinical pharmacology of imipramine. Implications for therapeutics.Arch Gen Psychiatry. 1973 May;28(5):649-53. doi: 10.1001/archpsyc.1973.01750350029006. Arch Gen Psychiatry. 1973. PMID: 4573419 Review. No abstract available.
Cited by
-
Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression.Sci Rep. 2015 Mar 9;5:8890. doi: 10.1038/srep08890. Sci Rep. 2015. PMID: 25749400 Free PMC article.
-
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.J Neural Transm. 1979;46(2):85-103. doi: 10.1007/BF01250331. J Neural Transm. 1979. PMID: 574536
-
The validity of animal models of depression.Psychopharmacology (Berl). 1984;83(1):1-16. doi: 10.1007/BF00427414. Psychopharmacology (Berl). 1984. PMID: 6429692 Review.
-
Phase I metabolism of imipramine by microsomes of small intestine in comparison with metabolism by liver microsomes.Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(2):176-82. doi: 10.1007/BF00634268. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6888570
-
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramine.J Neural Transm. 1982;54(3-4):219-28. doi: 10.1007/BF01254931. J Neural Transm. 1982. PMID: 7130974
MeSH terms
Substances
LinkOut - more resources
Full Text Sources